Many of our members have great success with compounded GLP-1s, but for some, switching to a dual-agonist medication like compounded tirzepatide (which acts on both GLP-1 and GIP receptors) can be a game-changer
When a source says one is stronger than the other, it is lining up REDEFINE 1s roughly 20.4% at 68 weeks against SURMOUNT-1s roughly 20.9% at 72 weeks two numbers from two different trials, in different populations, over different durations, against different comparators
Frequency of injections varies, but many people get them once or twice a week, with initial results often noticed after 3-4 weeks of consistent treatment

Since your desired product is out of stock Here are some premium alternatives that might interest you Alluvi Healthcare BPC-157 & TB-500 40mg Prefilled Pen, USA - Europe - Asia Fast Delivery 4,600/BoxCurrently out of Stock UBM Pharmaceuticals GST 12 yrs 4.3 (300) 61% Response Rate Out of Stock This product is currently unavailable Submit Your Requirement Find related categories More Products from UBM Pharmaceuticals Metylcobalamine Injection 110/Vial L Arginine Proanthocyanidin Sachet 48.50/Pack UBM Premium Protein Powder 420/Jar True Vital Multivitamin Multimineral Tablet 115/Strip Product Specification Product Description Each BPC-157 & TB-500 40mg Pen Kit Includes: X1 Pre-filled Research pen 40mg total 20mg - BPC-157 20mg - TB-500 Additional Information Product Image About the Company GST Registration Year 2021 Legal Status of Firm Proprietorship Nature of Business Trader - Wholesaler/Distributor Number of Employees 11 To 25 People Annual Turnover 1.5 - 5 Cr IndiaMART Member Since Mar 2014 GST 24**********1ZR Established In 2021, UBM Pharmaceuticals Has Made a Well-Recognized Name As a Manufacturer, Wholesaler and Trader of Pharmaceutical Tablets, Pharmaceutical Syrup and More.

COA included on request
Improvement of psoriasis during exenatide treatment in a patient with diabetes